Engineering Enzymes Offers Potential Treatments for ALS and Parkinson's

Researchers at Washington University in St. Louis have engineered enzymes that could treat neurodegenerative diseases like ALS and Parkinson's. This breakthrough has significant implications for potential treatments and the future of neurological research. The development could lead to new therapeutic options for patients suffering from these conditions.